ABCLAbCellera Biologics Inc.
What is the market doing?
No clear lean: insiders cluster-buying, but heavily shorted (+11% of shares).
Choppy, but holding above its 200-day average. Price is +80% vs its 200-day average.
Multiple insiders bought with their own money, the strongest form of the signal (the 90 days ending Oct 22, 2026).
Heavily shorted, settled Sep 30, 2026, about a week of normal trading to cover. Down 4.2% since the previous count, down from 15.8% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ABCL is trading
AbCellera Biologics Inc. is +103% over the past year while the S&P 500 is +16%: 87 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- +80%
vs 200-day average · a clear uptrend
- RSI (14)
- 34
RSI (14) · neutral
- Below its 52-week high
- 20%
Below its 52-week high
Details›
- Last close2026-10-23
- $11.83
- 1 monthS&P 500 −0.94%
- −6.5%
- 1 yearS&P 500 +16%
- +103%
- 5 yearsS&P 500 +86%
- −20%
- vs 50-day average$12.13
- −2.5%
- 52-week high
- $14.82
- 52-week low
- $2.78
- Annualised volatility
- 80%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-22
- $1.6M
| Year | Return |
|---|---|
| 2026 (year to date) | +246% |
| 2025 | +17% |
| 2024 | −49% |
| 2023 | −44% |
| 2022 | −29% |
| 2021 | −64% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 4 of 6 | +0.27% |
| Feb | 6 | 0 of 6 | −12% |
| Mar | 6 | 1 of 6 | −5.9% |
| Apr | 6 | 2 of 6 | −5.6% |
| May | 6 | 4 of 6 | +5.4% |
| Jun | 6 | 3 of 6 | +14% |
| Jul | 6 | 3 of 6 | −1.5% |
| Aug | 6 | 3 of 6 | +13% |
| Sep | 6 | 4 of 6 | +7.5% |
| Oct | 6 | 3 of 6 | −2.7% |
| Nov | 5 | 3 of 5 | −0.78% |
| Dec | 5 | 1 of 5 | −3.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.